ame004

Adam Ertel, PhD

Contact Dr. Ertel

233 South 10th Street
BLSB 1009
Philadelphia, PA 19107

(215) 503-7452
(215) 503-9142 fax

Most Recent Peer-reviewed Publications

  1. Blockade of Tumor-Expressed PD-1 promotes lung cancer growth
  2. Cell cycle-coupled expansion of AR activity promotes cancer progression
  3. Dystrophic Epidermolysis Bullosa: COL7A1 Mutation Landscape in a Multi-Ethnic Cohort of 152 Extended Families with High Degree of Customary Consanguineous Marriages
  4. RB loss promotes prostate cancer metastasis
  5. Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations including nephropathy
  6. Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
  7. v-Src oncogene induces Trop2 proteolytic activation via cyclin D1
  8. Genome-wide redistribution of MeCP2 in dorsal root ganglia after peripheral nerve injury
  9. Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia
  10. The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a CXCL signaling module
  11. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer
  12. Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the connectivity map database
  13. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis
  14. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines
  15. A community computational challenge to predict the activity of pairs of compounds
  16. A community effort to assess and improve drug sensitivity prediction algorithms
  17. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness
  18. Retinoblastoma protein potentiates the innate immune response in hepatocytes: Significance for hepatocellular carcinoma
  19. The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer
  20. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation